Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 1/2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
Evaluation of the Ocular Safety of Calcium Formate in Normal, Healthy Female Subjects
This is a Phase I, single center, open-label study of the dietary supplement calcium formate in normal, healthy female subjects. The purpose of the study is to determine whether daily use of calcium formate is safe and whether it accumulates in the eye.
100 Clinical Results associated with Nephro-Tech, Inc.
0 Patents (Medical) associated with Nephro-Tech, Inc.
100 Deals associated with Nephro-Tech, Inc.
100 Translational Medicine associated with Nephro-Tech, Inc.